| abstract |
The present invention relates to compounds of structural formula (I) which are useful as inhibitors of protein kinases. The invention also relates to pharmaceutically acceptable compositions comprising said compounds and methods of using said compositions in the treatment of various diseases, disorders or disorders. The invention also provides methods of preparing the compounds of the invention. In one embodiment, the invention is the manufacture of a compound of the invention, or a pharmaceutically acceptable salt or composition thereof, for use in treating or preventing a protein kinase mediated disease in a subject. In another embodiment, the compounds of the invention, their pharmaceutically acceptable salts, and compositions are for the study of kinases in biological and pathological phenomena; intracellular signal transduction pathways mediated by such kinases. And in the comparative evaluation of new kinase inhibitors. |